Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026)
Capricor Therapeutics (CAPR) recorded quarterly Other Non Operating Income of -$72998.0 in Q1 2026, up 47.17% quarter-over-quarter from -$138188.0 in Q1 2025, and up 47.17% on a YoY basis from -$49599.5 in Q1 2025.
Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$72998.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 47.17% year-over-year to -$72998.0; the TTM figure through Mar 2026 stood at $118711.0 (up 33.14% YoY), while the FY2025 annual figure was -$112098.0, down 6.42% from the prior year.
- Other Non Operating Income was -$72998.0 for Q1 2026 at Capricor Therapeutics, up from -$138188.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of -$72998.0 in Q1 2026 to a low of -$138188.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Capricor Therapeutics | 1.63 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72,998.00 |
| Mar 31, 2025 | -138,188.00 |
| Jun 30, 2021 | 318,160.00 |
| Sep 30, 2013 | 11,737.00 |
| Jun 30, 2013 | -102,545.00 |
| Mar 31, 2013 | -144,705.00 |
| Dec 31, 2012 | 117,466.00 |
| Sep 30, 2012 | 9,771.00 |
| Jun 30, 2012 | 420,890.00 |
| Mar 31, 2012 | -2,250.00 |
| Dec 31, 2011 | -513.00 |
| Sep 30, 2011 | 10,411.00 |
| Jun 30, 2011 | -1,341.00 |
| Mar 31, 2011 | -168.00 |
| Dec 31, 2010 | 244,478.00 |
| Sep 30, 2010 | -2,711.00 |
| Jun 30, 2010 | -40.00 |